JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.83B |
| 2 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.45B |
| 3 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.34B |
| 4 |
EA
Electronic Arts
EA
|
+$903M |
| 5 |
Automatic Data Processing
ADP
|
+$825M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.63B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.06B |
| 3 |
Meta Platforms (Facebook)
META
|
+$942M |
| 4 |
Nike
NKE
|
+$779M |
| 5 |
Union Pacific
UNP
|
+$543M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.97% |
| 2 | Technology | 12.33% |
| 3 | Healthcare | 10.23% |
| 4 | Consumer Discretionary | 8.25% |
| 5 | Industrials | 7.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1876
CarGurus
CARG
$3.38B
| $13.8M | ﹤0.01% |
247,319
+167,404
| +209% | +$7.74M |
|
1877
PUT
Las Vegas Sands
LVS
$29.6B
| $13.8M | ﹤0.01% |
232,100
+110,000
| +90% | +$7.38M |
|
1878
Invesco S&P Spin-Off ETF
CSD
$235M
| $13.8M | ﹤0.01% |
250,671
+55,628
| +29% | +$3.06M |
|
1879
CALL
CME Group
CME
$96.1B
| $13.8M | ﹤0.01% |
80,800
+25,800
| +47% | +$4.34M |
|
|
1880
PUT
CME Group
CME
$96.1B
| $13.8M | ﹤0.01% |
80,800
+14,800
| +22% | +$2.49M |
|
|
GBT
1881
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $13.8M | ﹤0.01% |
361,865
+48,188
| +15% | +$2.13M |
|
1882
Bio-Rad Laboratories Class A
BIO
$9.66B
| $13.7M | ﹤0.01% |
43,857
+13,398
| +44% | +$4.16M |
|
1883
Pediatrix Medical
MD
$2.14B
| $13.7M | ﹤0.01% |
294,049
-219,119
| -43% | -$10.1M |
|
1884
iShare MSCI Eurozone ETF
EZU
$9.96B
| $13.7M | ﹤0.01% |
333,895
-106,698
| -24% | -$4.42M |
|
|
TPCO
1885
DELISTED
Tribune Publishing Company Common Stock
TPCO
| $13.7M | ﹤0.01% |
836,356
+136,122
| +19% | +$2.26M |
|
1886
Fluor
FLR
$7B
| $13.7M | ﹤0.01% |
234,913
-318,896
| -58% | -$17.4M |
|
1887
PUT
AT&T
T
$168B
| $13.6M | ﹤0.01% |
537,014
-4,314,983
| -89% | -$106M |
|
1888
Brink's
BCO
$4.72B
| $13.6M | ﹤0.01% |
195,216
+113,022
| +138% | +$8.73M |
|
1889
AngioDynamics
ANGO
$647M
| $13.6M | ﹤0.01% |
624,365
-144,858
| -19% | -$3.22M |
|
|
SUNS
1890
DELISTED
SLR Senior Investment Corp. Common Stock
SUNS
| $13.6M | ﹤0.01% |
811,612
+36,287
| +5% | +$609K |
|
1891
New Mountain Finance
NMFC
$736M
| $13.6M | ﹤0.01% |
1,003,704
+309,406
| +45% | +$4.28M |
|
1892
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.88B
| $13.5M | ﹤0.01% |
427,718
-484,826
| -53% | -$15.5M |
|
1893
CALL
JD.com
JD
$39.6B
| $13.5M | ﹤0.01% |
517,900
+277,900
| +116% | +$9.1M |
|
1894
State Street SPDR S&P Metals & Mining ETF
XME
$4.46B
| $13.5M | ﹤0.01% |
394,483
-171,803
| -30% | -$5.99M |
|
|
AT
1895
DELISTED
Atlantic Power Corporation
AT
| $13.4M | ﹤0.01% |
6,109,497
+50,580
| +0.8% | +$110K |
|
1896
CALL
Eli Lilly
LLY
$1.08T
| $13.4M | ﹤0.01% |
125,200
+2,500
| +2% | +$250K |
|
|
GREK
1897
Global X MSCI Greece ETF
GREK
$331M
| $13.4M | ﹤0.01% |
540,000
-7,100
| -1% | -$188K |
|
1898
Turkcell
TKC
$4.72B
| $13.4M | ﹤0.01% |
2,784,989
+2,404,352
| +632% | +$12.7M |
|
|
ENBL
1899
DELISTED
ENABLE MIDSTREAM PARTNERS, LP
ENBL
| $13.4M | ﹤0.01% |
796,766
-792,210
| -50% | -$13.5M |
|
|
NUVA
1900
DELISTED
NuVasive, Inc.
NUVA
| $13.4M | ﹤0.01% |
188,976
-42,015
| -18% | -$2.67M |
|
Similar funds
JP Morgan Chase's Q3 2018 Portfolio in Review
As of Q3 2018, JP Morgan Chase held 6,019 positions worth $522B, up 7.4% from $486B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q3 2018 filing shows 449 new, 2,597 increased, 2,100 reduced and 313 closed positions. Its largest new stake was JPMorgan BetaBuilders Canada ETF: 29,437,708 shares worth $1.45B. The largest sale was Broadcom, an estimated $1.63B.
By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 14% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q3 2018 buy was JPMorgan BetaBuilders Canada ETF: 29,437,708 shares worth $1.45B.
- JP Morgan Chase added most to JPMorgan BetaBuilders Japan ETF in Q3 2018, an estimated $1.83B increase.
- JP Morgan Chase's biggest Q3 2018 reduction was Broadcom, cutting an estimated $1.63B.
- JP Morgan Chase fully exited Cavium, Inc. in Q3 2018, selling an estimated $316M.
- JP Morgan Chase's ten largest holdings make up 18% of its $522B portfolio in Q3 2018.
- JP Morgan Chase opened 449 new positions and closed 313 in Q3 2018.
- JP Morgan Chase's portfolio value rose 7.4% quarter-over-quarter to $522B.
Based on JP Morgan Chase's 13F filing for Q3 2018, filed 7 Nov 2018.